Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0271678X211026507 http://scihub22266oqcxt.onion/10.1177/0271678X211026507 34187231!8504942!34187231     free     free     free       J+Cereb+Blood+Flow+Metab 2021 ; 41 (10): 2797-2799 Nephropedia Template TP {{tp|p=34187231|t=2021. Recent advances in cell therapy for stroke |pdf=|usr=}}{{34187231}} gab.com Text Recent advances in cell therapy for stroke JO: J Cereb Blood Flow Metab http://www.kidney.de/pget.php?&tw=1&pmid=34187231 #FOAvip The last 50 years have witnessed the translation of stem cell therapy from the laboratory to the clinic for treating brain disorders, in particular stroke. From the focal stereotaxic transplantation to the minimally invasive intravenous and intraarterial delivery, stem cells display the ability to replenish injured cells and to secrete therapeutic molecules, altogether promoting brain repair. The increased stroke incidence in COVID-19 survivors poses as a new disease indication for cell therapy, owing in part to the cells' robust anti-inflammatory properties. Optimization of the cell transplant regimen will ensure the safe and effective clinical application of cell therapy in stroke and relevant neurological disorders. Twit Text FOAVip Recent advances in cell therapy for stroke ????J Cereb Blood Flow Metab http://www.kidney.de/pget.php?&tw=1&pmid=34187231 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34187231 #FOAvip English Wikipedia <ref>{{Cite pmid|34187231}}</ref> Recent advances in cell therapy for stroke #MMPMID34187231 Park YJ; Borlongan CV J Cereb Blood Flow Metab 2021[Oct]; 41 (10): 2797-2799 PMID34187231show ga The last 50 years have witnessed the translation of stem cell therapy from the laboratory to the clinic for treating brain disorders, in particular stroke. From the focal stereotaxic transplantation to the minimally invasive intravenous and intraarterial delivery, stem cells display the ability to replenish injured cells and to secrete therapeutic molecules, altogether promoting brain repair. The increased stroke incidence in COVID-19 survivors poses as a new disease indication for cell therapy, owing in part to the cells' robust anti-inflammatory properties. Optimization of the cell transplant regimen will ensure the safe and effective clinical application of cell therapy in stroke and relevant neurological disorders. |*Stem Cell Transplantation/methods[MESH] |Animals[MESH] |Brain/pathology[MESH] |COVID-19/*complications/diagnosis[MESH] |Humans[MESH] |Incidence[MESH] |Regenerative Medicine/methods[MESH] |SARS-CoV-2/isolation & purification[MESH]Recent advances in cell therapy for stroke (epmc).pdf DeepDyve Pubget Overpricing